CleveMed Blogs

Cleveland, OH - March 23, 2011 - Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTech (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as well as physiological monitors for research and education markets. Great Lakes NeuroTech (GLN) will perform R&D, engineering, manufacturing, distribution, and exporting of these technologies through two divisions: Movement Disorders and Research & Education Systems.

“Cleveland Medical Devices Inc. has been growing significantly in the areas of Sleep Disorders, Movement Disorders and Research / Education products. The spin-off will allow CMDI and GLN to further focus their efforts on their core competencies and dramatically boost their commercialization efforts”, said Robert Schmidt, CMDI’s Chairman. “The portability, quality, and cost efficacy of CMDI’s sleep monitoring products and web technologies such as SleepView, eCrytsal PSG, and Sapphire are leading the future of sleep medicine. This spin off will allow CMDI to quickly expand its market presence nationally and worldwide while continuing its excellence in R&D to serve the needs of more than 40 million sleep disorders patients”, said Robert Schmidt.

“The launch of Great Lakes NeuroTech transitions a proven line of innovative medical and research systems, an expert team of engineers and researchers, and high quality manufacturing to a new organization with a focus on these core technologies” said Joseph P. Giuffrida, PhD, GLN’s President. “The transition of technologies, marketing and manufacturing for the movement disorders and research & education product lines from CMDI to GLN is expected to occur in stages over the next few months with no interruption in quality, delivery and support to CMDI or GLN.”

GLN’s Division of Movement Disorders will target Parkinson’s disease and other movement disorders through a portfolio of patient-centered diagnostic and therapy systems integrated with wireless, remote, and web based technologies. Devices to be manufactured by GLN will include KinetiSense™, Kinesia™, and Kinesia HomeView™ systems for capturing movement disorder motor symptoms both in the clinic, at home, and during clinical trials. GLN will continue to grow the product portfolio through ongoing research and development funded by the National Institutes of Health in collaboration with key clinical opinion leaders in the field of movement disorders.

GLN’s Division of Research & Education Systems will market and manufacture a line of wireless physiological monitors and intelligent analysis software targeted to research and education markets. The BioRadio™ is a general purpose physiological monitor for capturing signals such as brain waves, muscle forces and activity, electrical heart activity, respiration, galvanic skin resistance, and pulse oximetry. The BioRadio is packaged in CleveLabs™, a lab course system with sessions for teaching physiology, psychology, health sciences, and biomedical engineering principles; and BioCapture™, a general purpose physiological research system. GLN will continue to expand the growing customer base for these technologies at universities and research institutes both domestically and internationally.

About CMDI

Cleveland Medical Devices Inc.’s mission is to develop, manufacture, and market innovative sleep disorders diagnostic and therapy products that improve the quality of life and reduce total health care costs for patients around the world.

About Great Lakes NeuroTech

Great Lakes NeuroTech is committed to pioneering innovative biomedical technologies to serve research, education, and medical communities, improving access to medical technology for diverse populations, and positively impacting quality of life for people around the world.

Media Contact

Maureen Phillips
Sales & Marketing Manager
216.619.5918
mphillips@GLNeuroTech.com

KinetiSense, Kinesia, Kinesia HomeView, BioRadio, CleveLabs, and BioCapture are trademarks of Cleveland Medical Devices Inc. of Cleveland OH provided under license to Great Lakes NeuroTech.

CleveMed’s DreamPort^™ was recently launched at Sleep 2009 in Seattle, WA:

DreamPort expands the reach of your sleep lab by allowing remotely attended sleep studies to be done from anywhere using a bedside system controlled by sleep lab technologists miles away - over the internet!

CleveMed showcased this innovative product with a Live Remotely Attended Sleep Study! A patient located in Cleveland, Ohio was hooked up to a Sapphire PSG™ which wirelessly transmitted the real time data to the DreamPort located in the patient’s room. Using the camera and broadband technology that the DreamPort provides, the patient’s full PSG data was viewed live by sleep technicians in Seattle, Washington at Sleep 2009!

DreamPort Benefits:

DreamPort is especially ideal for those who are unable to make it into the sleep lab, such as pediatric patients, cross country truckers, the elderly, those with chronic pain and hospital inpatients. In addition, this system gives clinicians and researchers greater flexibility to conduct sleep studies in anyplace. DreamPort is suitable for clinical trials as it allows for cost effective research studies to be conducted in the patient’s home while adding an additional element of home care. Moreover, DreamPort is easy to use. The small, portable and single-button design simplifies the overall process and deployment.

DreamPort’s Easy Process:

Step 1: Patient is hooked up with Sapphire PSG
Step 2: Patient pushes power button on DreamPort
Step 3: Sleep tech remotely starts study from sleep lab
Step 4: Sleep tech controls video and full PSG data remotely

Broadband technology combined with a camera is used to transmit the patient’s full PSG data and video to technologists in real-time, allowing studies to be conducted anywhere the patient is.

The CleveMed Sleep Team is at Sleep 2009 in Seattle, WA at Booth #929. Doors opened just a few hours ago and the team is very excited to present the pioneering concept of PSG Anywhere^™ to expand the reach of your sleep services.

Stop by and meet the team at Booth #929. And while you’re there, fill out a card for your chance to win an Amazon Kindle! The drawing for the winning card will be held at noon on Wednesday (June 10, 2009).

CleveMed will also be launching DreamPort^™ (coming soon), which expands the reach of your sleep by allowing remotely attended sleep studies to be done from virtually anywhere –over the internet! For the first time, the technologist can remotely monitor the patient data and video in real-time from almost any location using an extremely user-friendly and portable bedside system. DreamPort is ideal for testing patients who may have difficulty coming to the sleep lab and allows for cost effective research studies in patient homes.

Make sure to follow CleveMed at Sleep 2009 on Twitter at http://twitter.com/CleveMed. Check out what a fellow-tweeter said: ikg_agent@CleveMed Much victory…Booth #929 the way of the future